{"id":"https://openalex.org/W2069953817","doi":"https://doi.org/10.1097/qai.0b013e318213c2c0","title":"Safety, Efficacy, and Pharmacokinetics of TBR-652, a CCR5/CCR2 Antagonist, in HIV-1\u2013Infected, Treatment-Experienced, CCR5 Antagonist\u2013Naive Subjects","display_name":"Safety, Efficacy, and Pharmacokinetics of TBR-652, a CCR5/CCR2 Antagonist, in HIV-1\u2013Infected, Treatment-Experienced, CCR5 Antagonist\u2013Naive Subjects","alternate_titles":[],"publication_year":2011,"publication_date":"2011-02-12","ids":{"openalex":"https://openalex.org/W2069953817","doi":"https://doi.org/10.1097/qai.0b013e318213c2c0","mag":"2069953817","pmid":"https://pubmed.ncbi.nlm.nih.gov/21317794"},"language":"en","primary_location":{"id":"doi:10.1097/qai.0b013e318213c2c0","doi":"https://doi.org/10.1097/qai.0b013e318213c2c0","is_oa":false,"landing_page_url":"https://doi.org/10.1097/qai.0b013e318213c2c0","pdf_url":null,"source":{"id":"https://openalex.org/S157460402","display_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","issn_l":"1525-4135","issn":["1525-4135","1944-7884"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2069953817"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5002916327","display_name":"Jacob Paul Lalezari","orcid":"https://orcid.org/0000-0002-2744-4918","observed_orcids":["https://orcid.org/0000-0002-2744-4918"]},"institutions":[{"id":"https://openalex.org/I4210101066","display_name":"Quest Clinical Research (United States)","ror":"https://ror.org/019mfbd19","country_code":"US","type":"company","lineage":["https://openalex.org/I4210101066"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jacob Lalezari","raw_affiliation_strings":["Quest Clinical Research, San Francisco, CA, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Quest Clinical Research, San Francisco, CA, USA","institution_ids":["https://openalex.org/I4210101066"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113537282","display_name":"Joseph Gathe","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Joseph Gathe","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110434587","display_name":"Cynthia C Brinson","orcid":"https://orcid.org/0000-0002-3024-2815","observed_orcids":["https://orcid.org/0000-0002-3024-2815"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Cynthia Brinson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079664351","display_name":"Melanie Thompson","orcid":"https://orcid.org/0009-0005-0341-2400","observed_orcids":["https://orcid.org/0009-0005-0341-2400"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Melanie Thompson","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110140901","display_name":"Calvin\u00a0J. Cohen","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Calvin Cohen","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103806974","display_name":"Edwin DeJesus","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edwin Dejesus","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"Jorge Galindez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jorge Galindez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5103495124","display_name":"Jerome A. Ernst","orcid":"https://orcid.org/0009-0007-9398-8482","observed_orcids":["https://orcid.org/0009-0007-9398-8482"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Jerome A Ernst","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5088174722","display_name":"David E. Martin","orcid":"https://orcid.org/0000-0003-2820-5983","observed_orcids":["https://orcid.org/0000-0003-2820-5983"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"David E Martin","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":"https://openalex.org/A5035623095","display_name":"Sandra M. Palleja","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Sandra M Palleja","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.1684,"has_fulltext":false,"cited_by_count":66,"citation_normalized_percentile":{"value":0.95870069,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":86,"max":99},"biblio":{"volume":"57","issue":"2","first_page":"118","last_page":"125"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10526","display_name":"HIV/AIDS drug development and treatment","score":0.9951000213623047,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10112","display_name":"HIV Research and Treatment","score":0.004000000189989805,"subfield":{"id":"https://openalex.org/subfields/2406","display_name":"Virology"},"field":{"id":"https://openalex.org/fields/24","display_name":"Immunology and Microbiology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T10082","display_name":"HIV/AIDS Research and Interventions","score":0.00019999999494757503,"subfield":{"id":"https://openalex.org/subfields/2725","display_name":"Infectious Diseases"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ccr5-antagonist","display_name":"CCR5 antagonist","score":0.8450000286102295},{"id":"https://openalex.org/keywords/ccr2-antagonist","display_name":"CCR2 antagonist","score":0.9829999804496765},{"id":"https://openalex.org/keywords/hiv-1-infection","display_name":"HIV-1 infection","score":0.8460000157356262},{"id":"https://openalex.org/keywords/antiretroviral-naive-patients","display_name":"antiretroviral-naive patients","score":0.8339999914169312},{"id":"https://openalex.org/keywords/treatment-experienced-patients","display_name":"treatment-experienced patients","score":0.7580000162124634},{"id":"https://openalex.org/keywords/hiv-1-rna-suppression","display_name":"HIV-1 RNA suppression","score":0.7929999828338623},{"id":"https://openalex.org/keywords/cd4-count","display_name":"CD4 count","score":0.8460000157356262},{"id":"https://openalex.org/keywords/mcp-1","display_name":"MCP-1","score":0.902999997138977},{"id":"https://openalex.org/keywords/c-reactive-protein","display_name":"C-reactive protein","score":0.8320000171661377},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.9929999709129333},{"id":"https://openalex.org/keywords/pharmacokinetics","display_name":"pharmacokinetics","score":0.8970000147819519},{"id":"https://openalex.org/keywords/pharmacodynamics","display_name":"pharmacodynamics","score":0.9449999928474426},{"id":"https://openalex.org/keywords/safety-and-tolerability","display_name":"safety and tolerability","score":0.8500000238418579},{"id":"https://openalex.org/keywords/oral-antiretroviral-therapy","display_name":"oral antiretroviral therapy","score":0.6570000052452087}],"concepts":[{"id":"https://openalex.org/C112705442","wikidata":"https://www.wikidata.org/wiki/Q323936","display_name":"Pharmacokinetics","level":2,"score":0.7737461924552917},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.771432638168335},{"id":"https://openalex.org/C111113717","wikidata":"https://www.wikidata.org/wiki/Q725307","display_name":"Pharmacodynamics","level":3,"score":0.7475664615631104},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.7094012498855591},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.66066575050354},{"id":"https://openalex.org/C37044404","wikidata":"https://www.wikidata.org/wiki/Q5009692","display_name":"CCR5 receptor antagonist","level":5,"score":0.628095805644989},{"id":"https://openalex.org/C2776885963","wikidata":"https://www.wikidata.org/wiki/Q245204","display_name":"Antagonist","level":3,"score":0.55451899766922},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.5435414910316467},{"id":"https://openalex.org/C176674119","wikidata":"https://www.wikidata.org/wiki/Q11582","display_name":"Liter","level":2,"score":0.5283437967300415},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4763636589050293},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4551617205142975},{"id":"https://openalex.org/C90924648","wikidata":"https://www.wikidata.org/wiki/Q120569","display_name":"Gastroenterology","level":1,"score":0.4173394441604614},{"id":"https://openalex.org/C13373296","wikidata":"https://www.wikidata.org/wiki/Q421866","display_name":"Chemokine","level":3,"score":0.1951814591884613},{"id":"https://openalex.org/C2776914184","wikidata":"https://www.wikidata.org/wiki/Q101991","display_name":"Inflammation","level":2,"score":0.14361056685447693},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.1046740710735321},{"id":"https://openalex.org/C12823836","wikidata":"https://www.wikidata.org/wiki/Q24720618","display_name":"Chemokine receptor","level":4,"score":0.0824335515499115},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006207","descriptor_name":"Half-Life","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D007093","descriptor_name":"Imidazoles","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D007249","descriptor_name":"Inflammation","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012367","descriptor_name":"RNA, Viral","qualifier_ui":"Q000097","qualifier_name":"blood","is_major_topic":false},{"descriptor_ui":"D013454","descriptor_name":"Sulfoxides","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015497","descriptor_name":"HIV-1","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":true},{"descriptor_ui":"D015658","descriptor_name":"HIV Infections","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D018791","descriptor_name":"CD4 Lymphocyte Count","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000493","qualifier_name":"pharmacokinetics","is_major_topic":false},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D019380","descriptor_name":"Anti-HIV Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":false},{"descriptor_ui":"D019540","descriptor_name":"Area Under Curve","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D054390","descriptor_name":"Receptors, CCR2","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":true},{"descriptor_ui":"D055815","descriptor_name":"Young Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D065100","descriptor_name":"CCR5 Receptor Antagonists","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true}],"locations_count":2,"locations":[{"id":"doi:10.1097/qai.0b013e318213c2c0","doi":"https://doi.org/10.1097/qai.0b013e318213c2c0","is_oa":false,"landing_page_url":"https://doi.org/10.1097/qai.0b013e318213c2c0","pdf_url":null,"source":{"id":"https://openalex.org/S157460402","display_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","issn_l":"1525-4135","issn":["1525-4135","1944-7884"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310315671","host_organization_name":"Lippincott Williams & Wilkins","host_organization_lineage":["https://openalex.org/P4310315671","https://openalex.org/P4310318547"],"host_organization_lineage_names":["Lippincott Williams & Wilkins","Wolters Kluwer"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JAIDS Journal of Acquired Immune Deficiency Syndromes","raw_type":"journal-article"},{"id":"pmid:21317794","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/21317794","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of acquired immune deficiency syndromes (1999)","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":21,"referenced_works":["https://openalex.org/W1977407489","https://openalex.org/W1994135338","https://openalex.org/W2010061088","https://openalex.org/W2016168268","https://openalex.org/W2021008862","https://openalex.org/W2039244520","https://openalex.org/W2046208657","https://openalex.org/W2083451544","https://openalex.org/W2101044790","https://openalex.org/W2109357160","https://openalex.org/W2110709931","https://openalex.org/W2120153509","https://openalex.org/W2123272736","https://openalex.org/W2124347712","https://openalex.org/W2127517680","https://openalex.org/W2136227425","https://openalex.org/W2141860786","https://openalex.org/W2144032315","https://openalex.org/W2148597851","https://openalex.org/W2153136696","https://openalex.org/W2153741943"],"related_works":["https://openalex.org/W2141860786","https://openalex.org/W2021008862","https://openalex.org/W2057550019","https://openalex.org/W102418428","https://openalex.org/W2039244520","https://openalex.org/W2050977299","https://openalex.org/W2105965253","https://openalex.org/W2164585544","https://openalex.org/W2107817965"],"abstract_inverted_index":{"OBJECTIVES:":[0],"To":[1],"determine":[2],"the":[3,31,122,156,167],"antiviral":[4],"activity,":[5],"pharmacokinetics,":[6],"pharmacodynamics,":[7],"safety,":[8],"and":[9,34,71,80,90,103,108,126,134,169,179,188],"tolerability":[10],"of":[11,15,43],"several":[12],"dose":[13,46,171],"levels":[14,181,212],"oral":[16,238],"TBR-652":[17,49,184,198,218,230],"monotherapy":[18],"in":[19,30,40,68,117,166,202,210],"HIV-1-infected,":[20],"antiretroviral":[21],"experienced,":[22],"CCR5":[23,239],"antagonist-naive":[24],"subjects.":[25],"DESIGN:":[26],"Double-blind":[27],"placebo-controlled":[28],"study":[29],"United":[32],"States":[33],"Argentina.":[35],"METHODS:":[36],"Subjects":[37],"were":[38,75,97,111,130,143,182],"randomized":[39],"a":[41,214],"ratio":[42],"4:1":[44],"per":[45,138],"level":[47],"to":[48,147,195],"(25,":[50],"50,":[51,124],"75,":[52,125],"100,":[53],"or":[54,57],"150":[55,127],"mg)":[56],"placebo,":[58],"taken":[59],"once":[60],"daily":[61],"for":[62,81,121],"10":[63,165],"days.":[64,151],"Changes":[65],"from":[66],"baseline":[67],"HIV-1":[69,118,203],"RNA":[70,119,204],"CD4":[72,175],"cell":[73,176],"counts":[74],"measured":[76],"through":[77],"day":[78,93,164],"40":[79],"monocyte":[82],"chemotactic":[83],"protein-1":[84],"(MCP-1),":[85],"high-sensitivity":[86],"C-reactive":[87],"protein":[88],"(hs-CRP),":[89],"IL-6":[91,180],"at":[92,205],"10.":[94],"Pharmacokinetic":[95],"data":[96],"analyzed":[98],"using":[99],"noncompartmental":[100],"statistics.":[101],"Laboratory":[102],"clinical":[104],"adverse":[105],"events":[106],"(AEs)":[107],"electrocardiogram":[109],"changes":[110,142],"recorded.":[112],"RESULTS:":[113],"Maximum":[114],"median":[115],"reductions":[116,201],"values":[120],"25,":[123],"mg":[128],"doses":[129],"-0.7,":[131],"-1.6,":[132],"-1.8,":[133],"-1.7":[135],"log10":[136],"copies":[137],"milliliter,":[139],"respectively.":[140],"All":[141],"significant.":[144],"Median":[145],"time":[146],"nadir":[148],"was":[149,185,219],"10-11":[150],"Suppression":[152],"persisted":[153],"well":[154,189,221],"into":[155],"posttreatment":[157],"period.":[158],"Mean":[159],"MCP-1":[160,211],"increased":[161],"significantly":[162],"by":[163],"50-mg":[168],"150-mg":[170],"groups.":[172],"Effects":[173],"on":[174],"counts,":[177],"hs-CRP,":[178],"negligible.":[183],"generally":[186,220],"safe":[187],"tolerated,":[190],"with":[191,223,241],"no":[192,224],"withdrawals":[193],"due":[194],"AEs.":[196,226],"CONCLUSIONS:":[197],"caused":[199],"significant":[200],"all":[206],"doses.":[207],"Significant":[208],"increases":[209],"suggested":[213],"strong":[215],"CCR2":[216],"blockade.":[217],"tolerated":[222],"dose-limiting":[225],"Pharmacodynamics":[227],"indicate":[228],"that":[229],"warrants":[231],"further":[232],"investigation":[233],"as":[234],"an":[235],"unboosted":[236],"once-daily":[237],"antagonist":[240],"potentially":[242],"important":[243],"CCR2-mediated":[244],"anti-inflammatory":[245],"effects.":[246]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2069953817","counts_by_year":[{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":1},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":3},{"year":2020,"cited_by_count":5},{"year":2019,"cited_by_count":4},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":12},{"year":2014,"cited_by_count":6},{"year":2013,"cited_by_count":13},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-16T12:05:36.265796","created_date":"2016-06-24T00:00:00"}
